Browse by category

A systematic review and meta-analysis of studies, ‘Effects of Incretin-Based Therapies, Diet and Exercise interventions, and Bariatric Surgery on Fat-Free Mass in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis’, presented at the European Congress on Obesity in Istanbul, Turkey, shows that diet and exercise interventions result in a lower proportion of fat-free mass loss compared with bariatric surgery or obesity drugs among people undergoing a weight

Research from Italy presented at this year's European Congress on Obesity, Istanbul, Türkiye, shows that when the gold standard technique of dual-energy X-ray absorptiometry (DXA) is used to measure body fat in the general population, it shows that the traditional WHO body mass index (BMI) classification system misidentifies significant numbers of people as having overweight or obesity. In the past few years there has been a lot of criticism of the BMI system due to its inabi

Metabolic and bariatric surgery dramatically improves outcomes for patients with obesity and chronic kidney disease (CKD), significantly reducing the risk of kidney failure, major cardiovascular events (MACE) and death, according to research, ‘Long-term renal and survival outcomes in patients with obesity and chronic kidney disease following metabolic and bariatric surgery: A Trinetx cohort study (Abstract ID: 4520)’ presented at the annual meeting of the American Society for

Research presented at this year’s European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that those living with obstructive sleep apnoea (OSA) have a 71% higher risk of cardiovascular events (CVEs) or death from any cause (all-cause mortality) compared with those not living with OSA. OSA is characterised by recurrent upper airway obstruction during sleep and is associated with reduced quality of sleep and life and increased cardiovascular risk. The preval

A global panel of 21 obesity and cancer experts have suggested that to test the potential efficacy of the new generation of obesity drugs such as semaglutide and tirzepatide in preventing obesity-related cancer (ORC), a trial of the drugs for some 5,000 participants at high risk of cancer due to their having a cancer pre-cursor condition will provide the required answers. The group of experts, convened at the European Congress on Obesity (ECO2026) in Istanbul, Turkey, includi

Research from Italy presented at this year's European Congress on Obesity, Istanbul, Türkiye, shows that when the gold standard technique of dual-energy X-ray absorptiometry (DXA) is used to measure body fat in the general population, it shows that the traditional WHO body mass index (BMI) classification system misidentifies significant numbers of people as having overweight or obesity. In the past few years there has been a lot of criticism of the BMI system due to its inabi